News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Someone's Betting On Dendreon Corporation (DNDN)


4/10/2007 2:48:12 AM

Investors are betting that the U.S. Food and Drug Administration will break with tradition and approve Dendreon's prostate cancer treatment. The company's stock, which traded below $4 in March, soared 30.6% on Monday, to $23.58, a $5.53 gain.

>>> Discuss This Story


Read at Forbes
Read at Business Week

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES